Summit Therapeutics plc (SMMT Quick QuoteSMMT - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 79.2% in the past one-month time frame.

The company has seen one negative estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Summit Therapeutics currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is positive.

Another stock worth considering in the Medical - Drugs industry is Ionis Pharmaceuticals, Inc. (IONS Quick QuoteIONS - Free Report) , which also carries a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Is SMMT going up? Or down? Predict to see what others think:Up or Down

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>